44 results
424B5
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Prospectus supplement for primary offering
4:59pm
a classified board of directors that is divided into three classes with staggered three-year terms. Only the directors in one class will be subject
8-K/A
EX-99.3
3ns6i
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K/A
EX-99.4
kfko5 xpk547oue
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
EX-10.1
8bx6gt6z1y979u3sgch
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
S-3ASR
c59kcl2 81pvqzci
9 Sep 22
Automatic shelf registration
4:31pm
424B5
l9gq2s
10 Aug 22
Prospectus supplement for primary offering
5:07pm
424B5
v8r0e89x
9 Aug 22
Prospectus supplement for primary offering
12:00am